Keensight Capital

Keensight Capital is a prominent European growth buyout firm, headquartered in Paris, France, with a specialized focus on investing in profitable, fast-growing companies within the Technology and Healthcare sectors. The firm distinguishes itself by partnering closely with management teams, providing not only capital but also strategic guidance to accelerate growth through various initiatives, including organic expansion, international market penetration, and strategic mergers and acquisitions. Their investment philosophy centers on identifying businesses with strong fundamentals and significant potential for scaling, leveraging their deep industry expertise to drive value creation.

With a substantial presence in the European private equity landscape, Keensight Capital manages over €5 billion (approximately $5.4 billion) in assets, underscoring its significant financial capacity and commitment to its target sectors. The firm's latest fund, Keensight Capital Fund VI, successfully closed at €2.5 billion (approximately $2.7 billion) in 2023, demonstrating continued investor confidence and providing ample capital for future investments. Over its more than two decades of operation, Keensight Capital has built an impressive track record, having completed over 100 transactions, which highlights their extensive experience and consistent activity in the growth equity space.

Keensight Capital typically targets companies with revenues ranging from €10 million to €250 million, indicating their preference for established, yet still rapidly expanding, mid-market enterprises. Their typical investment ticket per transaction falls within the range of €20 million to €250 million. This flexible investment size allows them to accommodate a diverse set of opportunities, from significant minority stakes to control positions, always with the aim of fostering long-term value and supporting their portfolio companies in achieving their full potential. The firm's strategic approach and sector specialization position it as a key player for European technology and healthcare companies seeking growth capital and operational expertise.